Advanced search
Publication Cover
Future Medicinal Chemistry Volume 1, 2009 - Issue 7
Submit an article Journal homepage
96
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Exploring the Roles of Protein Kinases Using Chemical Genetics

Lucy M Elphick1 Division of Cell & Molecular Biology, Imperial College London, SW7 2AZ, UKView further author information
,
Sarah E Lee2 Department of Chemistry, University of Oxford, OX1 3TA, UKView further author information
,
Alexandra A Anderson1 Division of Cell & Molecular Biology, Imperial College London, SW7 2AZ, UKView further author information
,
Emma S Child1 Division of Cell & Molecular Biology, Imperial College London, SW7 2AZ, UKView further author information
,
Laurent Bonnac2 Department of Chemistry, University of Oxford, OX1 3TA, UKView further author information
,
Véronique Gouverneur2 Department of Chemistry, University of Oxford, OX1 3TA, UKCorrespondence[email protected]
View further author information
&
David J Mann1 Division of Cell & Molecular Biology, Imperial College London, SW7 2AZ, UKCorrespondence[email protected]
View further author information
 show all
Pages 1233-1241 | Published online: 21 Oct 2009

Bibliography

  • Cohen P . Protein kinases – the major drug targets of the twenty-first century?Nat. Rev. Drug Discov.1, 309–315 (2002).
  • Davies SP , ReddyH, CaivanoM, CohenP. Specificity and mechanism of action of some commonly used protein kinase inhibitors.Biochem. J.351, 95–105 (2000).
  • Senderowicz AM . Small-molecule cyclin-dependent kinase modulators.Oncogene22, 6609–6620 (2003).
  • Zhang J , YangPL, GrayNS. Targeting cancer with small molecule kinase inhibitors.Nat. Rev. Cancer9, 28–39 (2009).
  • Fabian MA , BiggsWH, TreiberDKet al. A small molecule-kinase interaction map for clinical kinase inhibitors. Nat. Biotechnol. 23, 329–336 (2005).
  • Karaman MW , HerrgardS, TreiberDKet al. A quantitative analysis of kinase inhibitor selectivity. Nat. Biotechnol. 26, 127–132 (2008).
  • Smukste I , StockwellBR. Advances in chemical genetics.Annu. Rev. Genomics Hum. Genet.6, 261–286 (2005).
  • Specht KM , ShokatKM. The emerging power of chemical genetics.Curr. Opin. Cell Biol.14, 155–159 (2002).
  • Xu W , DoshiA, LeiM, EckMJ, HarrisonSC. Crystal structures of c-Src reveal features of its autoinhibitory mechanism.Mol. Cell3, 629–638 (1999).
  • Shah K , ShokatKM. A chemical genetic screen for direct v-Src substrates reveals ordered assembly of a retrograde signaling pathway.Chem. Biol.9, 35–47 (2002).
  • Elphick LM , LeeSE, GouverneurV, MannDJ. Using chemical genetics and ATP analogues to dissect protein kinase function.ACS Chem. Biol.2, 299–314 (2007).
  • Randall CL , BurkardME, JallepalliPV. Polo kinase and cytokinesis initiation in mammalian cells: harnessing the awesome power of chemical genetics.Cell Cycle6, 1713–1717 (2007).
  • Hochegger H , DejsuphongD, SonodaEet al. An essential role for Cdk1 in S phase control is revealed via chemical genetics in vertebrate cells. J. Cell Biol. 178, 257–268 (2007).
  • Wang H , ShimizuE, TangYPet al. Inducible protein knockout reveals temporal requirement of CaMKII reactivation for memory consolidation in the brain. Proc. Natl Acad. Sci. USA 100, 4287–4292 (2003).
  • O‘Keefe SJ , MudgettJS, CupoSet al. Chemical genetics define the roles of p38α and p38β in acute and chronic inflammation. J. Biol. Chem. 282, 34663–34671 (2007).
  • Kim JS , LilleyBN, ZhangC, ShokatKM, SanesJR, ZhenM. A chemical-genetic strategy reveals distinct temporal requirements for SAD-1 kinase in neuronal polarization and synapse formation.Neural Develop.3, 23 (2008).
  • Qi ZH , SongM, WallaceMJet al. Protein kinase C ε regulates γ-aminobutyrate type A receptor sensitivity to ethanol and benzodiazepines through phosphorylation of γ2 subunits. J. Biol. Chem. 282, 33052–33063 (2007).
  • Liu Y , BishopA, WituckiLet al. Structural basis for selective inhibition of Src family kinases by PP1. Chem. Biol. 6, 671–678 (1999).
  • Miller AL , ZhangC, ShokatKM, LowellCA. Generation of a novel system for studying spleen tyrosine kinase function in macrophages and B cells.J. Immunol.182, 988–998 (2009).
  • Tatton L , MorleyGM, ChopraR, KhwajaA. The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases.J. Biol. Chem.278, 4847–4853 (2003).
  • Fan QW , ZhangC, ShokatKM, WeissWA. Chemical genetic blockade of transformation reveals dependence on aberrant oncogenic signaling.Curr. Biol.12, 1386–1394 (2002).
  • Kraybill BC , ElkinLL, BlethrowJD, MorganDO, ShokatKM. Inhibitor scaffolds as new allele specific kinase substrates.J. Am. Chem. Soc.124, 12118–12128 (2002).
  • Morgan DJ , WeisenhausM, ShumSet al. Tissue-specific PKA inhibition using a chemical genetic approach and its application to studies on sperm capacitation. Proc. Natl Acad. Sci. USA 105, 20740–20745 (2008).
  • Kenski DM , ZhangC, von Zastrow M, Shokat KM. Chemical genetic engineering of G protein-coupled receptor kinase 2. J. Biol. Chem.280, 35051–35061 (2005).
  • Papa FR , ZhangC, ShokatK, WalterP. Bypassing a kinase activity with an ATP-competitive drug.Science302, 1533–1537 (2003).
  • Hanke JH , GardnerJP, DowRLet al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271, 695–701 (1996).
  • Gregan J , ZhangC, RumpfCet al. Construction of conditional analog-sensitive kinase alleles in the fission yeast Schizosaccharomyces pombe. Nat. Protoc. 2, 2996–3000 (2007).
  • Bishop AC , Kung C-Y, Shah K, Witucki L, Shokat KM, Liu Y. Generation of monospecific nanomolar tyrosine kinase inhibitors via a chemical genetic approach. J. Am. Chem. Soc.121, 627–631 (1999).
  • Bishop AC , ShahK, LiuY, WituckiL, KungC, ShokatKM. Design of allele-specific inhibitors to probe protein kinase signaling.Curr. Biol.8, 257–266 (1998).
  • Cohen MS , ZhangC, ShokatKM, TauntonJ. Structural bioinformatics-based design of selective, irreversible kinase inhibitors.Science308, 1318–1321 (2005).
  • Blair JA , RauhD, KungCet al. Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. Nat. Chem. Biol. 3, 229–238 (2007).
  • Snead JL , SullivanM, LoweryDMet al. A coupled chemical-genetic and bioinformatic approach to Polo-like kinase pathway exploration. Chem. Biol. 14, 1261–1272 (2007).
  • Shah K , LiuY, DeirmengianC, ShokatKM. Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates.Proc. Natl Acad. Sci. USA94, 3565–3570 (1997).
  • Apsel B , BlairJA, GonzalezBet al. Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat. Chem. Biol. 4, 691–699 (2008).
  • Resnik JL , ReichartDB, HueyK, WebsterNJ, SeelyBL. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer.Cancer Res.58, 1159–1164 (1998).
  • Graff JR , KonicekBW, McNultyAMet al. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression. J. Biol. Chem. 275, 24500–24505 (2000).
  • Brognard J , ClarkAS, NiY, DennisPA. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.Cancer Res.61, 3986–3997 (2001).
  • Gorre ME , MohammedM, EllwoodKet al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293, 876–880 (2001).
  • Chu SH , SmallD. Mechanisms of resistance to FLT3 inhibitors.Drug Resist. Updat.12(1–2), 8–16 (2009).
  • Bikker JA , BrooijmansN, WissnerA, MansourTS. Kinase domain mutations in cancer: implications for small molecule drug design strategies.J. Med. Chem.52, 1493–1509 (2009).
  • Zunder ER , KnightZA, HousemanBT, ApselB, ShokatKM. Discovery of drug-resistant and drug-sensitizing mutations in the oncogenic PI3K isoform p110α.Cancer Cell14, 180–192 (2008).
  • Cheng AM , RowleyB, PaoW, HaydayA, BolenJB, PawsonT. Syk tyrosine kinase required for mouse viability and B-cell development.Nature378, 303–306 (1995).
  • Levin SE , ZhangC, KadlecekTA, ShokatKM, WeissA. Inhibition of ZAP-70 kinase activity via an analog-sensitive allele blocks T cell receptor and CD28 superagonist signaling.J. Biol. Chem.283, 15419–15430 (2008).
  • Negishi I , MotoyamaN, NakayamaKet al. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 376, 435–438 (1995).
  • Bashir T , PaganoM. Cdk1: the dominant sibling of Cdk2.Nat. Cell Biol.7, 779–781 (2005).
  • Larochelle S , MerrickKA, TerretMEet al. Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. Mol. Cell 25, 839–850 (2007).
  • Sabapathy K , HochedlingerK, NamSY, BauerA, KarinM, WagnerEF. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.Mol. Cell15, 713–725 (2004).
  • Tournier C , HessP, YangDDet al. Requirement of JNK for stress-induced activation of the cytochrome C-mediated death pathway. Science 288, 870–874 (2000).
  • Jaeschke A , KarasaridesM, VenturaJJet al. JNK2 is a positive regulator of the cJun transcription factor. Mol. Cell 23, 899–911 (2006).
  • Shirra MK , McCartneyRR, ZhangC, ShokatKM, SchmidtMC, ArndtKM. A chemical genomics study identifies Snf1 as a repressor of GCN4 translation.J. Biol. Chem.283, 35889–35898 (2008).
  • Das M , JiangF, SlussHKet al. Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc. Natl Acad. Sci. USA 104, 15759–15764 (2007).
  • Allen JJ , LazerwithSE, ShokatKM. Bio-orthogonal affinity purification of direct kinase substrates.J. Am. Chem. Soc.127, 5288–5289 (2005).
  • Allen JJ , LiM, BrinkworthCSet al. A semisynthetic epitope for kinase substrates. Nat. Methods 4, 511–516 (2007).
  • Blethrow JD , GlavyJS, MorganDO, ShokatKM. Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates.Proc. Natl Acad. Sci. USA105, 1442–1447 (2008).
  • Chi Y , WelckerM, HizliAA, PosakonyJJ, AebersoldR, ClurmanBE. Identification of CDK2 substrates in human cell lysates.Genome Biol.9, R149 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.